sPD-L1 levels have been revealed to not correlate with tumor PD-L1 expression in lung cancer [28, 39], brain tumors [49], pancreatic carcinoma [50], melanoma and renal cell carcinoma [25]. This evidence concerns the gene CD274 and exocrine pancreatic carcinoma.